Related Experiment Video
Updated: Aug 10, 2025
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
Neoadjuvant Radiation Therapy with Interdigitated High-Dose LRT for Voluminous High-Grade Soft-Tissue Sarcoma
Georges F Hatoum1, H Thomas Temple2, Silvio A Garcia1
1Department of Radiation Oncology, HCA Florida JFK Medical Center Comprehensive Cancer Institute, Lake Worth, FL, USA.
Cancer Management and Research
|February 13, 2023
Summary
A novel approach combining high-dose LATTICE radiation therapy (LRT) with standard radiation therapy safely treated large soft tissue sarcoma. This neoadjuvant strategy achieved over 95% tumor necrosis, paving the way for further clinical trials.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Soft tissue sarcomas are malignant tumors requiring effective treatment strategies.
- Neoadjuvant therapy aims to reduce tumor size and improve surgical outcomes.
- Novel radiation techniques are being explored to enhance treatment efficacy.
Observation:
- A case report details the treatment of a large extremity soft tissue sarcoma (2933 cc).
- The treatment involved interdigitating high-dose LATTICE radiation therapy (LRT) with standard radiation therapy.
- Four sessions of high-dose LRT were administered weekly, interspersed with standard radiation therapy.
Findings:
- The neoadjuvant regimen was well-tolerated by the patient.
- Post-operative assessment revealed negative surgical margins.
- Over 95% tumor necrosis was achieved, indicating significant treatment response.
Implications:
- This novel interdigitated radiation approach appears feasible and safe for soft tissue sarcoma.
- The strategy shows potential for increasing pathologic necrosis rates, correlating with improved survival.
- Further investigation in a phase-I/II trial is warranted to confirm toxicity and efficacy.
